#USA #Rochester #Nanodropper #MediSplit Program #MedOne

Overview of the MediSplit Program

In an innovative healthcare initiative, MedOne, a pharmacy benefit manager (PBM), collaborates with Nanodropper to enhance the medication experience for users of prescription eye drops through their MediSplit program. The program is articulated on a new value-based clinical care path that not only aims to improve patients' adherence to their eye drop regimens but also to reduce unwanted side effects associated with eye drop medications.

Significance of the Collaboration

The MediSplit program aims to alleviate the common challenges faced by patients who rely on prescription eye drops, which include issues such as medication waste, inconsistent dosing, and side effects linked to excessive systemic exposure. To tackle these issues, eligible MedOne members receive complimentary Nanodroppers when they fill certain ophthalmic prescriptions. This is a significant step towards making medication management more streamlined and effective.

Nanodropper's innovative device reduces the size of each eye drop, which allows patients to use less medication while extending the life of their prescriptions. When implemented throughout MedOne's extensive pharmacy network, this method holds the potential to revolutionize patient outcomes and cost management for healthcare plans.

Impressive Early Results

Initial outcomes from the MediSplit program have been quite remarkable. Key findings include:

• - Complete Adherence: Every participant (100%) reported never missing a dose due to running out of medication. This is a drastic improvement from the previous rate of 40%.
• - Reduced Side Effects: All participants (100%) indicated they no longer miss a dose because of side effects, a reduction from 20% prior to the program.
• - High Satisfaction: Again, 100% of participants expressed interest in continuing to receive Nanodroppers.
• - Fewer Side Effects: A notable 36% reported less frequent side effects, while 53% experienced a decrease in the intensity of side effects.

These results highlight the substantial benefits of marrying innovative medical devices with pharmacy benefits, leading to improved clinical and behavioral outcomes.

Expert Insights

Dr. Nathan Harold, Chief Pharmacy Officer at MedOne, commented on the collaboration, stating, "Our partnership with Nanodropper is a pivotal addition to this clinical program, concentrating on minimizing waste and delivering savings to both patients and healthcare providers. Our clients expect us to be responsible stewards of healthcare resources, and the MediSplit program embodies our commitment to them."

Moreover, this new pharmacy benefit design integrates medical devices as a vital service with a course of action aimed at patient results rather than mere usage rates. The program demonstrates how simple approaches can significantly improve both medication adherence and the overall treatment experience for patients.

Financial Implications

The financial benefits of the MediSplit program are equally compelling. Participants using eye drop medications typically costing health plans around $399 monthly now see significant reductions. Key metrics include:

• - Cost Reduction: A remarkable 36% drop in prescription drug costs for enrolled patients.
• - Average Savings: Each claim sees an average saving of $105.
• - Per-Month Savings: Savings may reach up to $160 PMPM for specific medications.

These early financial outcomes further underscore the value-focused nature of the MediSplit program, proving that enhanced clinical results can coexist with significant cost savings for payers and employers alike.

Future Outlook

As the healthcare landscape continues to evolve, stakeholders are increasingly in search of innovative solutions that balance cost with quality of care. The MediSplit program stands as a testament to the successful integration of medical devices within a value-oriented pharmacy strategy.

Dr. Song, CEO and Founder of Nanodropper, noted, "MedOne's initiative to launch the MediSplit program marks a pivotal transition toward an outcomes-driven pharmacy care model. The early achievements validate how precision tools can enhance adherence, lessen side effects, and bolster value-based care frameworks for both payers and employers."

Conclusion

Overall, the MediSplit program embodies a forward-thinking approach to pharmacy benefit management. By addressing the direct needs of patients through innovative solutions, MedOne and Nanodropper are setting a standard that highlights the impactful merging of technology and healthcare, potentially revolutionizing patient care and medication management in the field of ophthalmics. This initiative emphasizes the need for ongoing exploration of strategies that yield both better health outcomes and reduced healthcare expenses.